SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bharat Parenterals - Quaterly Results

08 Aug 2024 Evaluate
The sales for the June 2024 quarter moved up 31.68% to Rs. 920.60 millions as compared to Rs. 699.10 millions during the corresponding quarter last year.Net Profit recorded in the quarter ended June 2024 rise to 37.01% to Rs. 121.80  millions  compared to R. 88.90 millions in corresponding previous quarter.Operating profit for the quarter ended June 2024 rose to 188.80 millions as compared to 143.50 millions of corresponding quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 920.60 699.10 31.68 920.60 699.10 31.68 2541.60 2179.80 16.60
Other Income 39.00 28.60 36.36 39.00 28.60 36.36 119.50 188.40 -36.57
PBIDT 188.80 143.50 31.57 188.80 143.50 31.57 403.90 402.10 0.45
Interest 10.20 8.80 15.91 10.20 8.80 15.91 31.90 21.90 45.66
PBDT 178.60 134.70 32.59 178.60 134.70 32.59 372.00 380.20 -2.16
Depreciation 16.10 15.10 6.62 16.10 15.10 6.62 64.00 58.50 9.40
PBT 162.50 119.60 35.87 162.50 119.60 35.87 308.00 321.70 -4.26
TAX 40.70 30.70 32.57 40.70 30.70 32.57 82.10 78.30 4.85
Deferred Tax -2.75 -1.40 96.43 -2.75 -1.40 96.43 -4.50 -5.70 -21.05
PAT 121.80 88.90 37.01 121.80 88.90 37.01 225.90 243.40 -7.19
Equity 65.24 57.75 12.97 65.24 57.75 12.97 58.20 57.70 0.87
PBIDTM(%) 20.51 20.53 -0.09 20.51 20.53 -0.09 15.89 18.45 -13.85

Bharat Parenterals Share Price

1213.10 32.30 (2.74%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×